Skip to main content
Premium Trial:

Request an Annual Quote

Spectrumedix Dissolves, Transgenomic to Maintain Service, Supply Stream

NEW YORK (GenomeWeb News) — Spectrumedix, a maker of high-throughput capillary-electrophoresis tools, closed its doors last month, according to Transgenomic, a Spectrumedix distributor.
 
To make up for the resulting supply problems created by the dissolution, which occurred March 9, Transgenomic said it has purchased “certain assets” from the company’s court-appointed receiver along with a license to a gel patent it needs to make consumables for the Spectrumedix systems.
 
Transgenomic will continue to offer service and support to Spectrumedix customers in the US and elsewhere. The company said Spectrumedix-made tools are used in comparative genome scanning, SNP genotyping, heterozygote identification, fragment sizing, PCR quality testing, and custom assay development.
Transgenomic CEO Craig Tuttle said the company has been “concerned” about the supply of consumables and spare parts to its customers in Europe, and said this series of moves “clarifies the situation” for former Spectrumedix customers as well.
 
Financial terms of the deal were not released.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.